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Executive Summary 
 
The effects of preventable healthcare associated infections (HAIs) on patients and families, and the 
associated cost to the healthcare system, have become a prominent national healthcare issue.  This report 
provides the background and history of the Massachusetts Department of Public Health (MDPH) efforts to 
address the serious public health issue of HAI, data related to HAI in Massachusetts acute care hospitals, 
and a summary of current and planned work. 
 
HAIs are infections that patients acquire during the course of receiving medical treatment for other 
conditions within a healthcare setting.  Massachusetts acute care hospitals have been required to report 
specific HAI measures to MDPH since July of 2008.  Seventy-three hospitals have provided data for this 
report.   
 
One goal of the report is to help consumers better understand HAIs and the work being done to prevent 
their occurrence.  Some of the data highlight individual hospitals and allow comparison of infection rates to 
national rates.  The data is not designed to compare individual hospitals to one another, but is intended to 
be used over time to monitor trends and to develop targeted improvement strategies.  MDPH will use the 
data to identify issues and to inform public health policy.  
 
The selection of measures presented in this report was guided by recommendations of the Centers for 
Disease Control and Prevention (CDC) who emphasized the importance of considering frequency, severity 
and preventability of HAIs and the ability to detect and report them accurately.  The initial measures that 
best meet these criteria are central venous catheter blood stream infections (CLABSIs) and surgical site 
infections (SSIs).  Additional measures will be collected from health care providers over time.    
 
This is the first report containing hospital-specific data.  In future years, additional measures will be reported 
at the hospital level.  This data is self-reported and MDPH will be working with hospitals and the CDC to 
develop an ongoing program for validating the data.  This is the next step in ensuring standardization across 
hospitals for optimal interpretation.  
 
In an effort to raise awareness, promote transparency for healthcare consumers and motivate hospitals to 
prioritize infection prevention, several states require reporting of selected HAIs to their health authorities 
and some make this information available to the public.  It is important to keep in mind that the goal of public 
reporting is to influence and improve the quality of care provided in the Commonwealth.   
 
To assist the reader with some of the technical terms and abbreviations in this report, we 
have included a Glossary of Terms and Acronyms, found in Appendix A.
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Introduction 
 
This report presents information about healthcare associated infections (HAIs) reported by Massachusetts 
acute care hospitals to the National Healthcare Safety Network (NHSN) during the period July 1, 2008 – 
June 30, 2009.  NHSN is a U.S. Centers for Disease Control and Prevention (CDC) monitoring system that 
uses consistent national measures.  Participation in NHSN allows facilities to monitor HAI internally, and to 
measure results against national infection rates established by the CDC.  NHSN was the reporting system 
recommended by the HAI 2008 Expert Panel and Massachusetts acute care hospitals were required by 
regulation to enroll in NHSN by April 1, 2008.  
 
HAIs are infections that patients acquire during the course of receiving medical treatment for other 
conditions within a healthcare setting.  HAIs can result from unintentional exposure to bacteria, viruses, 
fungi or spores caused by transmission from contaminated healthcare workers’ hands, environmental 
surfaces, patient to patient contact, or staff failure to consistently use accepted prevention practices.  They 
can also be part of the patient’s underlying disease and a biologic problem not related to the health care 
itself. 
 
The information contained in this report represents hospital specific data for the following HAI measures:  
 Central line associated blood stream infections(CLABSI) in adult intensive care units (ICUs); 
 Central line associated blood stream infections (CLABSI) in pediatric intensive care units (PICUs); 
 Central line associated blood stream infections (CLABSI) in neonatal intensive care units (NICUs); 
 Surgical site infections (SSI) related to hip arthroplasties and; 
 Surgical site infections (SSI) related to knee arthroplasties.  
 
The report also provides aggregate information that does not identify hospitals for: 
 Surgical site infections (SSI) related to coronary artery bypass graft procedures (CABG); and 
 Surgical site infections (SSI) related to hysterectomies. 
 
Details about each of these measures are provided with the data. 
 
This report provides the first hospital specific reporting and analysis of HAIs for acute care hospitals in 
Massachusetts and offers an overview of the multi-faceted effort underway to address the complex issue of 
HAI.  Seventy-three hospitals provided data for the reporting period of July 1, 2008 through June 30, 2009.  
A listing of all of the reporting hospitals is in Appendix B. 
 
MDPH epidemiologists responsible for data analysis create and review detailed quality assurance reports 
for each hospital and send the reports to hospitals bi-monthly.  The epidemiologists work with hospitals to 
resolve any issues with the data. Hospital staff have the opportunity to review the hospital’s own data and 
make the necessary corrections in NHSN as directed.  This process provides ongoing guidance to improve 
the accuracy of the self-reported HAI data. 
 
Individual hospitals treat different types of patients and provide different levels and types of care therefore 
not all hospitals collect and report data for all of the selected measures.   
 
The intent of public reporting is to raise awareness, to provide consumers with information to guide 
healthcare decision-making and to encourage health care providers to reduce the occurrence of HAI.  
MDPH is committed to not only collecting, analyzing and reporting HAI data but also to providing support for 
HAI prevention and training activities.   
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Background 
 
In 1999 the Institute of Medicine (IOM) published To Err is Human – Building a Safer Health System, a 
groundbreaking report that raised awareness of the problems associated with the quality of healthcare in 
the United States.1  In addition to identifying the significant harm to patients and financial costs associated 
with medical errors, it highlighted healthcare associated infection (HAI) as an important problem affecting 
the American healthcare system.  This document received widespread attention from the public, the 
healthcare industry, and state and federal policy-makers and has resulted in an increased focus on 
improving quality and safety in healthcare including efforts to address HAI.  
 
Scope of the Problem  
The CDC estimates that nearly two million patients develop one or more HAIs which contribute to 99,000 
deaths annually 2, making HAI one of the leading causes of death in the United States.  
 
Four types of infection account for more than 80% of all infections acquired in the healthcare setting:  
 catheter associated urinary tract infections (CAUTI); 
 surgical site infections (SSI);  
 ventilator associated pneumonia (VAP) and; 
 central line associated blood stream infections (CLABSI).   
 
These infections not only have a negative personal impact on patients and their families, they are also 
adding to the nation’s escalating healthcare costs.  According to a cost analysis performed in 2007, the 
annual economic burden of HAI in Massachusetts ranges from $200 to $400 million annually.3  A recent 
CDC report estimates the U.S. direct medical cost of treating HAI ranges from $35.7 billion to $45 billion 
annually.4  While the economic burden for healthcare systems and individuals is large, the most difficult cost 
to measure is the substantial impact these infections have on patients and their families.   
 
History of Prevention and Control of HAI in Massachusetts 
 
The prevention and control of HAI is a national priority and many individuals, state and federal government 
agencies, providers, and private organizations are working to meet this healthcare challenge.  MDPH is the 
agency responsible for monitoring diseases and environmental, occupational or chronic conditions 
throughout the state.  State law provides the health department with the legal and regulatory authority to 
conduct surveillance and investigate the causes of communicable and other infectious disease outbreaks 
(105 CMR 300).   
 
Massachusetts hospitals are also actively involved in HAI reduction activities intended to make care better 
and safer for patients. All hospitals licensed by MDPH are required to have a hospital-wide program for the 
prevention, control, and investigation of infectious diseases.  These programs are managed by nurses, 
physicians, medical technologists, and other professionals who have acquired special training in infection 
control or epidemiology.  Since the 1970’s, hospitals have been collecting and analyzing data on HAI and 
on healthcare practices that have been shown to reduce the risk of HAI.  Hospitals routinely collect this data 
                                                 
1 National Academy of Science, Institute of Medicine. To Err is Human: Building a Safer Health System. Kohn L, Corrigan J, 
Donaldson M, eds. 1999. 
2  Klevens RM, Edwards JR, Richards CL Jr. et al. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 
2002. Public Health Rep. 2007; 122: 160-6.  www.cdc.gov/ncidod/dhqp/pdf/hicpac/infections_deaths.pdf 
3 http://www.mass.gov/Eeohhs2/docs/dph/patient_safety/haipcp_final_report_pt1.pdf  
http://www.mass.gov/Eeohhs2/docs/dph/patient_safety/haipcp_final_report_pt2.pdf 
4 http://www.cdc.gov/ncidod/dhqp/pdf/Scott_CostPaper.pdf 
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to track internal performance, analyze institution-specific quality improvement, monitor trends within their 
facilities and target interventions for prevention and control.   
 
In Massachusetts’ landmark Health Reform Law, Chapter 58 of the Acts of 2006, a provision directed the 
MDPH Division of Health Care Quality to develop a Statewide Infection Prevention and Control Program. 
Program development was guided by an HAI Expert Panel that conducted a comprehensive assessment of 
the key issues surrounding HAI and formulated a substantial set of evidence-based recommendations and 
best practice guidelines including the public reporting of HAI measures by hospitals.  Following the 
recommendations of the Expert Panel, the Public Health Council adopted an amendment to hospital 
licensure requiring acute care hospitals to report specific HAI related data beginning July 1, 2008.  A 
preliminary report of four months of aggregate data was released by MDPH in April 2009.5   
 
Chapter 58 also established the Health Care Quality and Cost Council (HCQCC), a mandated entity 
charged with identifying statewide goals for improving health care quality, containing health care costs, and 
reducing racial and ethnic disparities in health care.  The Council receives input and advice from an 
Advisory Committee that includes representation from consumers, business, labor, health care providers, 
and health plans.  Among the Council’s specific strategies is the public reporting of HAIs and serious 
reportable events.  MDPH Commissioner John Auerbach serves as a member of the Council.  
 
A timeline of the development of the Massachusetts Infection Prevention and Control Program and the 
reporting and monitoring of HAIs is found in Appendix C.   
 
HAI Expert Panel 
 
Beginning in 2006, in collaboration with the Betsy Lehman Center for Patient Safety and Medical Error 
Reduction, MDPH brought together a panel of experts and key stakeholders to make recommendations for 
a statewide infection prevention and control program, including the potential reporting of HAI measures by 
hospitals.  With the assistance of JSI Research and Training Institute, six Task Groups and an ad hoc 
pediatric subcommittee, involving additional local and national experts, reviewed available evidence and 
developed specific proposals for prevention and reporting of HAI.  The final report of the Expert Panel was 
presented to MDPH and the Lehman Center on January 31, 2008.  The information in this report provided 
the framework for the Statewide Infection Prevention and Control Program.  The full report and 
recommendations can be found at www.mass.gov/dph/dhcq 
 
The HAI Expert Panel Report: Prevention and Control of Healthcare-Associated Infections in Massachusetts 
was also published by the Agency for Health Research and Quality’s National Guideline Clearinghouse™ 
(NGC)6.  The NGC is a public resource for evidence-based clinical practice guidelines. 
 
Technical Advisory Group  
 
Following completion of the work of the HAI Expert Panel, an aggressive program to implement the 
recommendations began.  In addition to the broad dissemination of the evidence-based recommendations 
and the adoption of mandatory reporting, a multidisciplinary HAI Technical Advisory Group (TAG) was 
established to advise MDPH on all aspects of the statewide HAI Prevention and Control Program.  The TAG 
initially met in April 2008, and is chaired by the State Epidemiologist.  The group’s membership also 
includes hospital epidemiologists, infection preventionists, consumers and advocates, quality improvement 
professionals, representatives of insurers, and the hospital association.  The TAG has provided ongoing 
guidance on all HAI issues including the results of reports and surveys, the application of surveillance and 
                                                 
5 http://www.mass.gov/Eeohhs2/docs/dph/quality/healthcare/hai_prelim_report.pdf 
Massachusetts Department of Public Health  
Healthcare Associated Infection Report  
April 14, 2010  
7
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control methods and the presentation of the results to healthcare providers and the public.  The TAG meets 
quarterly and all meetings are open to the public.  A full listing of TAG members and affiliations can be found 
in Appendix D.   
 
Data Reporting Process 
 
In 2008, licensure regulations for acute care hospitals were revised to incorporate requirements for 
reporting of HAI to MDPH and the Betsy Lehman Center (105 CMR 130.1701).  Beginning July 1, 2008, 
hospitals were mandated to report central line associated blood stream infections (CLABSI) and surgical 
site infections (SSI) occurring as a result of selected orthopedic, cardiac and gynecological procedures to 
MDPH and the Betsy Lehman Center.  The primary platform for data submission is the CDC’s NHSN.  A 
preliminary aggregate report of NHSN data, representing the first 4 months of CLABSI and SSI reporting, 
was released by MDPH April 2009.7  
 
In summary, the data are submitted to NHSN, quality assurance reports are created by MDPH 
epidemiologists and reviewed with the hospitals, and the hospitals may make corrections.  In the next phase 
of Massachusetts’ HAI work, there will be an additional data validation process, involving chart review and 
additional work with hospitals in detecting HAI.   
 
National Healthcare Safety Network (NHSN) 
 
All infections reported to NHSN must meet the standard definition of an HAI: 
A localized or systemic condition resulting from an adverse reaction to the presence of an infectious toxin(s) 
and there must be no evidence that the infection was present or incubating at the time of admission to the 
care setting.  Clinical evidence may be derived from direct observation of the infection site or review of 
information in the patient chart or other clinical records.8 
 
Participation in NHSN requires a considerable commitment by each hospital.  Qualified infection 
preventionists (IPs) conduct HAI surveillance.  IPs are professionals trained in nursing, microbiology, 
epidemiology or medical technology who have obtained additional education in infection prevention and 
control.  Data entry can only be performed by NHSN users who have completed training on the CDC 
definitions and surveillance methodology and all protocols must be followed exactly.  This provides a 
rigorous national and state standard of consistent collection of comparable data.  Once data is entered it is 
immediately available to hospitals, NHSN, and MDPH for viewing, analysis and editing.  Hospitals are 
authorized to view only their own facility or group specific information.  
 
When collecting HAI data, facilities must enter information on all of the required procedures not just 
procedures resulting in infection.  This means detailed information must be reported for every patient 
undergoing a procedure under surveillance in a hospital not just the small number of patients who develop 
infections.   
 
Although not originally established as a system for mandatory reporting, twenty one states are currently 
using or planning to use NHSN to fulfill these requirements.  CDC made NHSN available to all United States 
healthcare facilities at no charge in June, 2007 and is currently collecting data from more than 2400 facilities 
in all fifty states.   
 
                                                 
7 http://www.mass.gov/Eeohhs2/docs/dph/quality/healthcare/hai_prelim_report.pdf 
8 http://www.cdc.gov/nhsn/PDFs/pscManual/2PSC_IdentifyingHAIs_NHSNcurrent.pdf 
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Additional HAI Reporting  
 
In addition to reporting specific HAI measures to MDPH through NHSN, there are two data collection 
initiatives underway that utilize alternative systems for data submission.  All acute care Massachusetts 
hospitals are currently collecting a uniform set of data on influenza vaccination rates of hospital personnel 
and have participated in a methicillin-resistant Staphylococcus aureus (MRSA) point prevalence survey for 
patients in intensive care units.   
 
Influenza Vaccination Reporting  
Influenza (the flu) is a contagious respiratory illness caused by influenza viruses.  The most effective 
method of preventing influenza virus infection and its potentially serious complications is to immunize.  The 
majority of health care workers have not been vaccinated against seasonal flu in the past, despite the 
recommendation of numerous professional agencies and organizations including the CDC, the National 
Foundation for Infectious Diseases (NFID), the Infectious Diseases Society of America (IDSA) and The 
Joint Commission.  According to the CDC, only 44% of health care workers received influenza vaccine 
during the 2006-2007 season.9  Influenza vaccination provides protection for workers in health care settings 
and reduces risk in the patients they care for.   
 
To gain a better understanding of the current rate of vaccine coverage and to evaluate the merit of this 
measure for public reporting, during the 2008-09 influenza season, MDPH required acute care hospitals to 
report their success in providing influenza vaccine to health care workers to the Betsy Lehman Center for 
Patient Safety.  Data were reported at two time points, January 31, 2009 and March 31, 2009.  The 
information was used to assess the reliability of the measure and the comparability across hospitals.  Rates 
submitted for individual hospitals during this period were not made public but were used to inform policy 
changes implemented during the 2009-2010 influenza season.  Slight modifications were made to the 
methodology for collecting this data for the 2009-2010 influenza season.  Acute care hospitals are now 
required, pursuant to regulations promulgated in the fall of 2009, to report seasonal influenza vaccination 
rates of hospital personnel to MDPH no later than April 15, 2010.  Analysis of this data will be made 
available to the public in a report to be issued by the fall of 2010.    
 
Methicillin-resistant Staphylococcus aureus (MRSA) Point Prevalence 
 
MRSA is a type of Staphylococcus aureus (“staph”) bacteria that is resistant to some kinds of antibiotics.  
There has been increasing attention to MRSA from healthcare professionals and the media.  Experts in the 
field agree that understanding the burden of MRSA is important when trying to decide how to try to prevent 
or control it in a facility.  Point prevalence surveys measure the proportion of people in a specific group who 
have a disease or condition at a particular time. It provides a snapshot of the disease at a point in time.  
Point prevalence surveys are valuable tools that hospitals can use to estimate their overall MRSA problem.   
 
As part of the Infection Prevention and Control Program, MDPH required all acute care hospitals to 
complete a one day collection of MRSA nasal cultures during the week of September 15-19, 2008 for 
patients in ICUs and report the information to the Betsy Lehman Center for Patient Safety.  The preliminary 
findings from the first survey did not signal a need for procedural changes, but following consultation with 
the TAG, it was recommended that the survey be repeated to provide a second round of data collected.  
Neonatal intensive care units (NICUs) were excluded from the second screening survey due to low MRSA 
rates observed in the 2008 survey.  All acute care ICUs excluding NICUs were required to report MRSA 
                                                 
9 
 
CDC Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 
2009.MMWR 2009; 58(Early Release):1-52   
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point prevalence conducted on a single day during the week of September 14-18, 2009 to MDPH.  Analysis 
of this data is underway and a brief report will be issued by fall 2010.   
 
 
Massachusetts Data: July 1, 2008 – June 30, 2009 
 
Using this Data – Important Information to Consider 
 
It is important to consider the following when reviewing the data presented in this report: 
 
 The overall quality and safety of a hospital should not be determined by the single measure of HAI.  
Many factors contribute to a hospital’s quality of care. 
 Age, underlying illnesses, and severity of disease place some patients at higher risk for infection. 
 This data should not be used to compare hospitals. Results are affected by the types of patients 
treated in a hospital, the variety of services provided by the hospital, the intensity of surveillance 
efforts, and the interpretation of surveillance criteria, all of which can differ from hospital to hospital 
and make comparisons misleading.   
 Hospitals that treat more complex patients with greater risk for infection may have higher rates. 
 Sometimes high rates are based on small numbers, so both the number and the rate should be 
reviewed.  
 The term “expected infections” is used in some of the data tables.  This is a statistical term that 
predicts the number of infections a hospital would have, if that hospital had exactly the same 
infection rate as the national average.   
 A higher rate of infection may indicate a true problem or simply better surveillance.  A lower rate may 
reflect fewer infections, fewer high risk patients, or different levels of infection surveillance.  
 Data submission was evaluated for completeness and accuracy, but, a formal process for data 
validation was not possible for this reporting period.  An initiative to develop, pilot test and implement 
a statewide validation plan is currently under development and will be described in greater detail 
later in the report.   
 
A glossary is included as Appendix A to help in understanding some of the abbreviations and terms 
in this report. 
 
NHSN definitions are used throughout this report.  It should be noted that NHSN’s definition of a major 
teaching hospital is different from definitions used in other contexts.10 
 
Standardized Infection Ratio (SIR) 
The standardized infection ratio (SIR) is a measure that is used to compare how a single hospital’s rates of 
infection compare to a ‘gold standard’.  In this case, that standard is the national rates reported by CDC in 
their annual report. The SIR compares the actual number of events at each hospital to an expected number 
of events.  The expected number of events is calculated based on the national average rates of infection 
multiplied by the number of days people had a central line at the hospital or how many surgeries the 
hospital performed.  If the SIR is 1, there is no difference between the number of events at the location in 
question and the national average.  If the number is less than 1, there were fewer events at that location 
than expected, and if the number is above 1 there were more events at that location than expected. 
 
                                                 
10 http://www.cdc.gov/nhsn/PDFs/dataStat/2009NHSNReport.PDF 
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The national average rates of infection are reported separately, or stratified, according to locations where a 
person is being cared for or characteristics of the patient or the surgery such as how long the surgery took 
to perform or how sick a person was before they had the surgery, as these characteristics change the risk of 
someone getting an infection. The tables below are similarly stratified to provide a proper comparison. 
  
The SIR is calculated as: 
 Actual Number of Infections 
Expected Number of Infections  Standardized Infection Ratio (SIR) = 
 
This is a standard ratio that can be used to compare hospital performance over time.  It is not designed to 
explicitly compare hospitals to one another. 
 
How do we evaluate the SIR: Statistical Significance and Confidence Intervals?  
 
As mentioned above, we use the SIR to compare Massachusetts hospitals to the national averages. A SIR 
of 1 would indicate that a hospital is doing the same as the national average.  However, what does an SIR 
of 1.7 mean?  Looking at the interpretation above, the hospital has more events than expected, but is it a lot 
more?  To answer this question, we use statistical testing to determine if that difference has meaning or if 
the variation may be due to chance.  Throughout the data section the terms “statistically significant” or 
“statistically different” will appear to indicate when the number of infections is different in a meaningful way 
from the number expected on the basis of the national average rate applied to the number of procedures or 
catheter days. 
 
We use these tests because the national average is really an estimate. NHSN does not capture every 
infection in every hospital in the United States.  In addition, while we try to account for some things that put 
a patient more at risk for infection, the system does not capture every detail about every person.  Each 
patient and location has a different set of risks that cannot fully be accounted for in the calculation of the 
SIR. Statistics provide us with some tools to interpret variability.  We are able to calculate a range for the 
SIRs for which we are 95% confident that the true value would fall into if we could take everything into 
account.  We call this a 95% confidence interval. If the value 1 falls within this range, we say that the actual 
value is not statistically significantly different.  If the range does not include 1 then the actual value is 
statistically significantly different from 1.  The 95% confidence interval is largely based on the underlying 
sample, in this case, the number of central line days or the number of surgeries in a given location.  With a 
larger sample, the confidence interval is narrower because the estimate is based on more observations.  
 
The goal of all hospitals in Massachusetts is zero infections.  Some hospital locations have reported no 
infections during this initial reporting period.  There could be many explanations for why other hospitals 
have reported one or more infections.  It may not be due to any different infection control methods used, but 
rather because of the different types of patients, the conditions for which they are treated, and specialized 
levels of care required.  It is also important to note that the data included in this report was collected over a 
relatively short time period, and that even a single infection makes a significant impact on the rates 
reported.  One of the next steps for our program is to work with hospitals on validating the data and help 
them to continue to improve their processes for identifying and reporting infections. 
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Hospital Characteristics 
 
Seventy-eight Massachusetts hospitals reported data to NHSN in the reporting period, and selected results 
from the seventy-three acute care sites are reported here.  (Hospitals not included in this report do not meet 
the definition of acute care hospitals; they are state, non-acute facilities or specialty care centers).  Most 
acute care hospitals reporting are general hospitals; two are children’s hospitals and one is an orthopedic 
specialty hospital.  The hospitals nearly all operate as not-for-profit; 6 are owned and operated by for-profit 
organizations (8%).  Forty-four percent of the hospitals had at least limited teaching status, with 26% being 
major teaching hospitals.  A major teaching hospital is defined here as a facility that is an important part of 
the teaching program of a medical school and where the majority of medical students rotate through 
multiple clinical services.  This is an NHSN definition and is different from definitions often used in other 
contexts.11 
 
Nearly half of the hospitals have fewer than 100 beds; 10 have more than 300. 
 
 
Table 1.  Number of Hospitals by Bed Size 
 
Bed Size Category Number of Hospitals 
<100 beds 31 
100-199 beds 21 
200-299 beds 10 
300+ beds 11 
 
 
A smaller number of beds will result in a smaller number of patient days, which impacts the rates of infection 
calculated.  One additional infection at a hospital with a smaller number of beds will have a much greater 
impact on infection rate than one additional infection at a larger hospital.  This is important to keep in mind 
when looking at a hospital’s data. 
 
Infection Preventionists (IPs) 
IPs play a critical role in preventing infections and are part of the team that analyzes the root cause of HAI.  
As their name suggests, infection preventionists are staff members at hospital facilities, both inpatient and 
outpatient, who oversee infection prevention and control efforts.  They are most commonly nurses, but can 
also have backgrounds in other areas such as microbiology.   
 
Although the infection prevention and control program guides the effort, reducing the risk of HAIs is a 
hospital-wide responsibility, requiring teamwork and a multidisciplinary approach.  Preventing HAIs must be 
a hospital priority and part of the overall institutional commitment to improvement including senior 
leadership involvement to ensure the allocation of resources to address HAIs.   
 
The expert panel reviewed infection preventionist staffing and noted that the number of beds per infection 
preventionist at that time was higher than a recent national report’s suggested ratio of 125 beds per 
infection control preventionist.  Particularly in the larger hospitals, the number of beds per infection 
preventionist remains higher than these recommendations.  
                                                 
11 http://www.cdc.gov/nhsn/PDFs/dataStat/2009NHSNReport.PDF 
Massachusetts Department of Public Health  
Healthcare Associated Infection Report  
April 14, 2010  
12
 
Table 2:  Beds per 1 Full Time Equivalent (FTE) of Infection Preventionists by Bed Size Category 
 
Beds per 1 FTE Infection Preventionist 
Bed size category 
Mean Median Minimum Maximum 
<100 beds 43 30 7 99 
100-199 beds 132 149 28 189 
200-299 beds 216 234 101 270 
300+ beds 203 164 99 343 
 
 
 
Central Line Associated Blood Stream Infection (CLABSI) 
  
A central venous catheter (CVC), sometimes known as a central line, is a special type of flexible tube that is 
placed into a large vein in the chest, arm, neck or groin and ends at or close to the heart or one of the great 
vessels.  In newborns, the umbilical artery or vein is considered a great vessel.  CVCs are used to 
administer fluids, nutrition, chemotherapy, antibiotics, blood and blood products, to monitor the 
cardiovascular system, for hemodialysis or to draw blood.  They are an essential part of caring for a critically 
ill person, but their use also potentially places patients at increased risk for serious infections.  
 
Central line associated bloodstream infections (CLABSI) are bloodstream infections occurring in a patient 
that had a central line within the 48 hour period before the development of the infection.12 They are 
sometimes also referred to as a central venous bloodstream infections, or CVC-BSI.  CDC provides 
definitions of three different types of CLABSI, called Criterion 1, Criterion 2, and Criterion 3.   
 
An estimated 248,000 bloodstream infections occur in U.S. hospitals each year.13  The cost to the 
healthcare system is approximately $25,000 per episode.14 CLABSIs can be prevented through proper 
insertion and care of the central line. 
 
All Massachusetts acute care hospitals are required to monitor and report CLABSIs occurring in all patients 
receiving treatment in ICUs.  Patients requiring intensive care are usually sicker, require complex treatment 
and are at highest risk for HAI. 15   
 
There are many different types of ICUs, each with different types of patients.  Not all hospitals have each 
type of ICU.  Examples include medical, cardiac, trauma, and neurosurgical.  Each type of ICU differs in 
how frequently they use central lines, which contributes to risk for infection; greater use of central lines 
means more opportunity for infections to occur in that ICU. 
 
Identifying and classifying CLABSIs can be complex and relies upon the healthcare provider to interpret 
signs, symptoms, and test results.  The definitions and some simple examples follow.  Real-life cases are 
often more complicated.  A summary of the definitions can also be found in Appendix E. 
                                                 
12 http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf 
13 Klevens RM, Edward JR, et al. Estimating Health Care-Associated Infections and Deaths in U.S. hospitals, 2002. Public Health 
Reports 2007; 122:160-166. 
14 Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-Related Infections. MMWR 
Morb Mortal Wkly Rep. 2002; 51(RR- 10):3–36. 
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15 Klevens RM, Edward JR, et al. Estimating Health Care-Associated Infections and Deaths in U.S. hospitals, 2002. Public Health 
Reports 2007; 122:160-166. 
 
In a criterion 1 infection, the patient has a recognized “true” pathogen cultured from one or more blood 
cultures and the organism cultured from blood is not related to an infection at another site.   
 
For example: Mr. Smith is a patient in Hospital A’s surgical intensive care unit (ICU) and has a central line in 
place.  Blood is drawn and tested.  The results show an infection caused by an organism called 
Staphylococcus aureus, which is a true pathogen.  Mr. Smith does not have infection at any other body site.  
Mr. Smith’s case meets all of the requirements for a criterion 1 CLABSI. 
 
Criterion 2:  The patient has at least one of the following signs or symptoms: fever >38°C (>100.4°F), chills, 
or hypotension and signs and symptoms and positive laboratory results are not related to an infection at 
another site, with a common skin microorganism (i.e., diphtheroids [Corynebacterium spp.], Bacillus [not B. 
anthracis] spp., Propionibacterium spp., coagulase-negative staphylococci [including S. epidermidis], 
viridans group streptococci, Aerococcus spp., Micrococcus spp.) is cultured from two or more blood cultures 
drawn on separate occasions. 
 
For example:  Ms. Doe is in Hospital B’s medical ICU.  She has a central line in place.  She has a fever of 
101oF (38. 3°C).  Blood is drawn and tested.  The results show Staph coag negative in the blood.  This 
organism is normally found on the skin, but has the potential to cause infections.  In order to see if this 
might be a criterion 2 infection, one day later more blood is drawn and tested.  The second blood sample 
also finds Staph coag negative.  She has no other infections at other sites.  Ms. Doe now meets the 
definition of a criterion 2 infection. 
 
As you can see, Ms. Doe has an organism in her blood that is normally found on the skin.  She was 
required to have two blood cultures, in order to be sure that the blood sample was not contaminated when it 
was being collected.   
 
Criterion 3 characteristics are similar to criterion 2 infections, but apply only to patients less than 1 year of 
age.  The patient must have has at least one of the following signs or symptoms: fever (>100.4oF core), 
hypothermia (96.8oF core), apnea, or bradycardia.  The signs and symptoms and positive laboratory results 
are not related to an infection at another site and common skin contaminant (i.e., diphtheroids 
[Corynebacterium spp.], Bacillus [not B. anthracis] spp., Propionibacterium spp., coagulase-negative 
staphylococci [including S. epidermidis], viridans group streptococci, Aerococcus spp., Micrococcus spp.) is 
cultured from two or more blood cultures drawn on separate occasions.    
 
In this report, criterion 1 CLABSIs are presented separately, as well as part of the total CLABSI reporting.  
The initial recommendation of the HAI Expert Panel was to report criterion 1 for public reporting, as the 
definition is the most easily applied across hospitals and there is less room for mis-classification of 
infections.    
 
When Massachusetts CLABSI rates are compared to national rates, they are statistically lower in the most 
common types of ICUs, both in an all-criteria comparison and a criterion 1 only comparison. 
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Table 3:  Massachusetts Criterion 1, 2, and 3 CLABSI Rates Compared to National Rates, by ICU Type 
 
ICU type 
Number 
of 
Locations
All 
Criteria 
BSI 
BSI per 
1,000 
Central 
Line Days
National 
Rate SIR 
Compared to 
National Rate
Burn 2 11 5.06 5.5 0.92 Statistically No Different 
Medical all others 2 0 0.00 1.9 0.00 Statistically No Different 
Medical cardiac 13 19 1.18 2 0.59 Statistically Lower 
Medical major teaching 14 59 1.77 2.6 0.68 Statistically Lower 
Medical/surgical all others 46 41 1.00 1.5 0.67 Statistically Lower 
Medical/surgical major 
teaching 9 16 0.95 2.1 0.45 
Statistically 
Lower 
Neurosurgical 2 6 1.21 2.5 0.48 Statistically No Different 
Pediatric cardiothoracic 1 27 4.59 3.3 1.39 Statistically No Different 
Pediatric medical 1 1 1.17 1.3 0.9 Statistically No Different 
Pediatric medical/surgical 6 21 2.62 3 0.87 Statistically No Different 
Surgical 14 36 1.19 2.3 0.52 Statistically Lower 
Surgical cardiothoracic 10 13 0.57 1.4 0.41 Statistically Lower 
Trauma 3 7 1.25 3.6 0.35 Statistically Lower 
 
 
 
Table 4:  Massachusetts Criterion 1 CLABSI Rates Compared to National Rates, by ICU Type 
 
ICU type 
Number 
of 
Locations
Criterion 
1 BSI 
BSI per 
1,000 
Central 
Line 
Days 
National 
Rate SIR 
Compared to 
National 
Rate 
Medical/surgical non major 
teaching 46 31 0.76 1.1 0.69 
Statistically 
Lower 
Medical major teaching 14 44 1.32 2.2 0.60 Statistically Lower 
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ICU type 
Number 
of 
Locations
Criterion 
1 BSI 
BSI per 
1,000 Compared to National SIR Central National Rate Line Rate 
Days 
Surgical 14 10 0.33 1.9 0.17 Statistically Lower 
Medical cardiac 13 12 0.74 1.6 0.47 Statistically Lower 
Surgical cardiothoracic 10 11 0.49 1.1 0.44 Statistically Lower 
Medical/surgical major 
teaching 9 10 0.59 1.6 0.37 
Statistically 
Lower 
Pediatric medical/surgical 6 16 2.00 2.4 0.83 Statistically No Different 
Trauma 3 3 0.54 3.1 0.17 Statistically Lower 
Burn 2 10 4.60 4.8 0.96 Statistically No Different 
Medical all others 2 0 0.00 1.5 0.00 Statistically No Different 
Neurosurgical 2 4 0.81 1.9 0.42 Statistically No Different 
Pediatric cardiothoracic 1 24 4.08 2.9 1.41 Statistically No Different 
Pediatric medical 1 0 0.00 1.2 0.00 Statistically No Different 
 
 
CLABSI Rates 
 
Table 5 shows the hospital-specific SIRs for criterion 1, 2 and 3 bloodstream infections in specific types of 
ICUs, by hospital.  Only the rates that are significantly different from the national rates are shown.  All other 
hospitals had ICUs with infection rates not significantly different from the national rates (confidence interval 
of SIR includes 1.00).  SIRs are calculated with the expected number of infections based on hospitals and 
ICUs of the same type (bed size, teaching status, etc; medical, surgical, medical-surgical, etc.)16.   
 
Actual Number of Events 
Expected Number of Events 
 
Standardized Infection Ratio (SIR) = 
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16 All ‘national data’ for comparison is from the “National Healthcare Safety network (NHSN) report: Data summary for 2006 through 
2008, issued December 2009” www.cdc.gov/nhsn/PDFs/dataStat/2009NHSNReport.pdf 
Table 5: Criterion 1, 2 and 3 CLABSI Infection Rates Significantly Different From National Rates17 
 
Hospital ICU type 
BSI Rate 
per 1,000 
Central 
Line Days 
(A) 
National 
Rate for 
Comparable 
ICU  
(B) 
SIR 
(A/B) 
Compared 
to National 
Rate 
Boston Medical Center Medical cardiac 0.32 2.0 0.16 Statistically Lower 
Boston Medical Center Surgical 0.56 2.3 0.25 Statistically Lower 
Boston Medical Center Trauma 0.90 3.6 0.25 Statistically Lower 
Brigham and Women's 
Hospital Surgical cardiothoracic 0.18 1.4 0.13 
Statistically 
Lower 
Brigham and Women's 
Hospital Surgical 0.97 2.3 0.42 
Statistically 
Lower 
Massachusetts General 
Hospital Medical cardiac 0.49 2.0 0.24 
Statistically 
Lower 
Massachusetts General 
Hospital Surgical cardiothoracic 0.23 1.4 0.16 
Statistically 
Lower 
Massachusetts General 
Hospital Neurosurgical 0.00 2.5 0.00 
Statistically 
Lower 
Massachusetts General 
Hospital Surgical 0.41 2.3 0.18 
Statistically 
Lower 
Saint Vincent Hospital Medical/surgical major teaching 0.00 2.1 0.00 
Statistically 
Lower 
UMass Memorial 
Medical Center Medical major teaching 1.42 2.6 0.55 
Statistically 
Lower 
UMass Memorial 
Medical Center Surgical 0.54 2.3 0.23 
Statistically 
Lower 
 
 
A table showing a comparison of all BSI rates for all hospitals and ICU types to national rates is in Appendix 
G.  
 
Table 6 shows the hospital-specific SIRs for criterion 1 bloodstream infections in specific types of ICUs.  
Only the rates that are significantly different from the national rates are shown.  All other hospitals had ICUs 
with infection rates not significantly different from the national rates (confidence interval of SIR includes 
1.00).  SIRs are calculated with the expected based on hospitals and ICUs of the same type (bed size, 
teaching status, etc; medical, surgical, medical-surgical, etc.)   
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Table 6: Criterion 1 CLABSI Infection Rates Significantly Different From National Rates18,19 
 
Hospital ICU type 
Criterion 
1 BSI 
Rate per 
1,000 
Central 
Line Days
(A) 
National 
Rate 
(B) 
SIR 
(A/B) 
Compared 
to National 
Rate 
Boston Medical Center Surgical 0.28 1.9 0.15 Statistically Lower 
Brigham and Women's 
Hospital Surgical cardiothoracic 0.18 1.1 0.16 
Statistically 
Lower 
Brigham and Women's 
Hospital Medical major teaching 0.71 2.2 0.32 
Statistically 
Lower 
Brigham and Women's 
Hospital Surgical 0.19 1.9 0.10 
Statistically 
Lower 
Caritas Carney Hospital Medical/surgical non major teaching 5.12 1.1 4.65 
Statistically 
Higher 
Lahey Clinic Medical major teaching 0.68 2.2 0.31 Statistically Lower 
Lahey Clinic Surgical 0.48 1.9 0.25 Statistically Lower 
Massachusetts General 
Hospital Medical cardiac 0.24 1.6 0.15 
Statistically 
Lower 
Massachusetts General 
Hospital Neurosurgical 0.00 1.9 0.00 
Statistically 
Lower 
Massachusetts General 
Hospital Surgical 0.20 1.9 0.11 
Statistically 
Lower 
Saint Vincent Hospital Medical/surgical major teaching 0.00 1.6 0.00 
Statistically 
Lower 
UMass Memorial Medical 
Center Medical major teaching 1.20 2.2 0.55 
Statistically 
Lower 
UMass Memorial Medical 
Center Surgical 0.00 1.9 0.00 
Statistically 
Lower 
UMass Memorial Medical 
Center Trauma 0.00 3.1 0.00 
Statistically 
Lower 
 
 
Massachusetts hospital infection rates generally compare well with national rates.  Only one Massachusetts 
hospital had a higher infection rate than the national rate.  The statistical methods used, and tests of 
statistical significance, are only intended for comparisons of a hospital to the national rate, not of one 
hospital to another. 
 
A table showing criterion 1 BSI rates for all hospitals and ICU types to national rates is in Appendix H.  
 
                                                 
18 Locations with <=12.5 patient days or central line days are excluded from the analysis (this results in one location being excluded) 
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19 All ‘national data’ for comparison is from the “National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 
2008, issued December 2009”  www.cdc.gov/nhsn/PDFs/dataStat/2009NHSNReport.pdf 
Central Line Utilization 
 
Without taking into account a hospital’s use of central lines, looking at a hospital’s infection data can be 
misleading. The use of central lines varies among different types of ICUs.  The following chart shows the 
number of days central lines were used in different types of ICUs, compared to the total number of patient 
days, which gives the central line utilization ratio. 
 
    
= Central Line Utilization Ratio
Total Central Line Days 
Total Patient Days  
 
 
Hospitals with higher central line utilization ratios use central lines more than hospitals with lower ratios.  
This can be due to a variety of factors, including the types of patients cared for in that hospital unit.  With 
more line days, there are more chances for their patients to get an infection.  Appendix I contains hospital-
specific central line utilization ratios. 
 
Table 7: Central Line Utilization Ratio by ICU Type – Massachusetts Acute Care Hospitals 
 
Type of ICU 
Number of 
Hospitals 
With This 
ICU Type 
Total Central 
Line Days (A) 
Total Patient 
Days (B) 
Central Line 
Utilization 
Ratio (A/B) 
Medical/Surgical, non major 
teaching 46 40,809 103,053 0.40 
Medical major teaching 14 33,327 50,530 0.66 
Surgical 14 30,280 46,756 0.65 
Medical cardiac 13 16,120 30,185 0.53 
Surgical cardiothoracic 10 22,613 28,769 0.79 
Medical/surgical major 
Teaching 9 16,921 31,954 0.53 
Pediatric medical/surgical 6 8,003 17,684 0.45 
Trauma 3 5,586 11,081 0.50 
Burn 2 2,172 2,317 0.94 
Medical, not major teaching 2 1,871 3,919 0.48 
Neurosurgical 2 4,968 11,813 0.42 
Pediatric cardiothoracic 1 5,877 7,964 0.74 
Pediatric medical 1 855 2,965 0.29 
 
 
Pathogens causing CLABSIs 
Pathogens are the microorganisms that cause infection.  They can be viruses, bacteria, or other 
microorganisms.  A few key pathogens have been identified as the causes of most of the CLABSIs 
occurring in Massachusetts hospitals.  Nearly half of the infections are caused by coagulase negative 
Staphylococcus (CoNS) and Enterococcus spp.  Although CoNS is identified as the most common 
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pathogen for CLABSI, it is important to know that CoNS is normally found on the skin and could 
contaminate the blood sample when it is drawn. 
 
 
Table 8: Pathogens Identified as Causing Reported Bloodstream Infections – All Criteria 
 
Pathogen Number of Infections 
Percent of Total 
Infections 
Coagulase–negative Staphylococcus 85 33% 
Enterococcus sp. 44 17% 
Gram-negative bacteria 43 17% 
Yeasts 38 15% 
Methicillin-resistant Staphylococcus aureus (MRSA) 20 8% 
Staphylococcus aureus (not MRSA) 14 6% 
Multiple organisms 8 3% 
Lactobacillus sp. 2 1% 
Bacillus sp. 1 0% 
Fungi (not yeast) 1 0% 
Streptococci (other than Enterococcus sp.) 1 0% 
Total 257 100% 
 
 
 
Neonatal Intensive Care Units (NICUs) 
 
Neonatal intensive care units (NICUs) care for premature or seriously ill newborns.  Additional specific 
measures are collected for NICUs, including birth weight, to help better reflect the potential reasons for 
differences in infection rates.  NICU type is a self-designated categorization chosen by hospitals when they 
first joined NHSN.  This designation was based on definitions of NICU level provided by CDC that were 
found to be interpreted differently by different hospitals, and that have since been clarified.  According to the 
updated CDC definitions, and according to MDPH regulations, all NICUs listed in this report are considered 
level III.  For the NHSN definitions of NICU levels, see Appendix J.   
 
As with other types of ICUs, it is important to consider the central line utilization ratio.  Without taking into 
account the hospital’s use of central lines, looking at a hospital’s infection data can be misleading.  
Hospitals using central lines more frequently have more opportunity for a CLABSI to occur.   
    
 Total Central Line Days 
Total Patient Days Central Line Utilization Ratio  =   
 
 
Table 9:  Neonatal Intensive Care Unit (NICU) Central Line Utilization 
 
Hospital NICU type 
Central 
Line 
Days (A) 
Patient 
days (B) 
Central Line 
Utilization 
Ratio (A/B) 
Beth Israel Deaconess Medical Center  Level II/III 1,908 13,657 0.14 
UMass Memorial Medical Center  Level II/III 2,285 12,381 0.18 
Baystate Medical Center  Level III 1,980 7,203 0.27 
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Hospital NICU type 
Central 
Line 
Days (A) 
Central Line Patient Utilization days (B) Ratio (A/B) 
Boston Medical Center  Level III 875 4,386 0.20 
Brigham and Women’s Hospital Level III 2,144 17,333 0.12 
Children’s Hospital Boston Level III 2,884 7,340 0.39 
Massachusetts General Hospital 20 Level III 949 2,708 0.35 
South Shore Hospital  Level III 669 2,433 0.27 
St. Elizabeth’s Medical Center Level III 474 3,536 0.13 
Tufts Medical Center  Level III 3,704 11,666 0.32 
 
 
The central line utilization ratios in NICUs range from 0.12 to 0.39.  This may reflect the seriousness of the 
patient’s conditions and types of treatments patients require or the variations may be due to differences in 
NICU infant populations, so this information should not be used to compare hospitals to one another. Since 
all patient days are the denominator, Massachusetts NICUs have large variability around which types of 
babies they admit (e.g. some NICUs admit all well infants <36 weeks gestation, or well infants with a 
peripheral IV for antibiotics while other NICUs never admit infants in these categories if the babies are 
well).  Obviously this would affect device utilization if the patient days are increased by adding well infants 
who never require a central line. 
 
Table 10 shows the SIR for NICUs in individual hospitals.  
 
 
 
 
Standardized Infection Ratio (SIR) = 
Actual Number of BSI per 1,000 central line days 
Expected Number of BSI per 1,000 central line days 
In this case, the SIR is the actual number of criterion 1, 2 and 3 BSI divided by the expected number of all 
Criterion BSI per 1,000 central line days, based on national averages.   
 
 
Table 10:  Neonatal Intensive Care Unit (NICU) Criteria 1, 2 and 3 BSI SIRs 
 
Hospital NICU type 
Criterion 1, 
2 and 3 BSI 
per 1,000 
Central 
Line Days 
 
Number 
of 
Infections
(A) 
Expected 
Number 
of 
Infections 
(B) 
SIR 
(A/B) 
Compared 
with 
National 
Rate 
Beth Israel Deaconess Medical 
Center 
Level 
II/III 2.62 5 6.09 0.82 
Statistically 
No Different 
UMass Memorial Medical Center Level II/III  3.06 7 5.91 1.19 
Statistically 
No Different 
Baystate Medical Center Level III 0.51 1 4.12 0.24 Statistically No Different 
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20 Please note MGH did not report NICU data via NHSN until January 2009.  The hospital reported the occurrence of two CLABSIs 
during the period of 7-08 through 12-08.   
Criterion 1, Expected 
Hospital NICU type 
2 and 3 BSI Number Compared Number SIR per 1,000 
Central 
Line Days 
 
of with of Infections
(A) Infections (B) 
(A/B) National 
Rate 
Boston Medical Center Level III 5.71 5 1.71 2.92 Statistically No Different 
Brigham and Women’s Hospital Level III 3.26 7 4.5 1.56 Statistically No Different 
Children’s Hospital Boston Level III 0.69 2 5.84 0.34 Statistically No Different 
Massachusetts General 
Hospital21 Level III 0 0 1.77 0.00 
Statistically 
No Different 
South Shore Hospital Level III 0 0 1.22 0.00 Statistically No Different 
St. Elizabeth’s Medical Center Level III 0 0 0.96 0.00 Statistically No Different 
Tufts Medical Center Level III 3.51 13 7.88 1.65 Statistically No Different 
 
Criteria 1, 2,and 3 BSIs are shown by birth weight in Appendix K. 
 
 
 
Table 11:  Neonatal Intensive Care Unit (NICU) Criterion 1 BSI SIR 
  
 
Hospital NICU type 
Criterion 1 
BSI per 
1,000 
Central 
Line Days 
 
Number 
of 
Infections 
(A) 
Expected 
Number 
of 
Infections  
(B) 
SIR 
(A/B) 
Compared 
with 
National 
Rate 
Beth Israel Deaconess Medical 
Center 
Level 
II/III  2.62 5 4.81 1.04 
Statistically 
No Different 
UMass Memorial Medical Center Level II/III  1.75 4 5.35 0.75 
Statistically 
No Different 
Baystate Medical Center Level III 0.51 1 5.30 0.19 Statistically No Different 
Boston Medical Center Level III 2.29 2 2.19 0.91 Statistically No Different 
Brigham and Women’s Hospital Level III 1.87 4 5.79 0.69 Statistically No Different 
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21 Please note MGH did not report NICU data via NHSN until January 2009.  The hospital reported the occurrence of two CLABSIs 
during the period of 7-08 through 12-08.   
Hospital NICU type 
Criterion 1 
BSI per 
1,000 
Central 
Line Days 
 
Number 
of 
Infections 
(A) 
Expected 
Number 
of 
Infections  
Compared 
SIR with 
(B) 
(A/B) National 
Rate 
Children’s Hospital Boston  Level III 0 0 7.46 0.00 Statistically Lower 
Massachusetts General 
Hospital22 Level III 0 0 2.34 0.00 
Statistically 
No Different 
South Shore Hospital Level III 0 0 1.58 0.00 Statistically No Different 
St. Elizabeth’s Medical Center Level III 0 0 1.27 0.00 Statistically No Different 
Tufts Medical Center Level III 3.24 12 10.16 1.18 Statistically No Different 
 
 
Only Children’s Hospital’s SIR is significantly different than the national rate, and it is statistically lower.   
 
Criterion 1 BSIs are shown by birth weight group in Appendix L. 
 
Pathogens 
CLABSIs in NICUs resulted from the following organisms.   
 
Table 12:  Pathogens Identified in NICU CLABSI 
 
Pathogen Number of Infections 
Percent of Total 
Infections 
Staphylococcus aureus (not MRSA) 15 38% 
Coagulase-negative Staphylococcus 12 30% 
Yeasts 5 13% 
Enterococcus 3 8% 
Gram–negative bacteria 3 8% 
Methicillin-resistant Staphylococcus aureus (MRSA) 2 5% 
Total 40 102%23 
 
 
Nearly 70 percent of CLABSIs in NICUs are caused by Staphylococcus aureus and coagulase-negative 
Staphylococcus sp.   
 
                                                 
22 Please note, MGH did not report NICU data via NHSN until January 2009.  The hospital reported the occurrence of two CLABSIs 
during the period of 7-08 through 12-08.    
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Surgical Site Infections (SSIs) 
 
Surgical site infections (SSIs) are infections that are directly related to an operative procedure.  SSIs 
develop within thirty days after an operation or within one year if an implant was placed and the infection 
appears to be related to the surgery.24  Some SSIs are less serious and only involve the skin or 
subcutaneous tissue.  Other SSIs may be deeper and are more significant.  Deep incisional and 
organ/space SSIs result in the greatest personal cost for patients and families, and additional financial 
burden on the health care system.  For this reason, acute care hospitals are required to report to MDPH 
deep incisional HAIs and infections that affect body organs or spaces.  For more detail about of how SSIs 
are classified, please see Appendix M.      
 
More than half of SSIs are not identified until patients are discharged from the hospital and patients with 
infection do not always return to the same hospital where the original surgery was performed.  Making 
identification of SSIs even more complex is that infections associated with implants can occur a 
considerable time after surgery (up to one year).  To identify infections after discharge and prevent 
underestimations of SSIs, hospital infection control programs routinely conduct a process known as post 
discharge surveillance.  Although there is no standard way to obtain this information, hospitals use various 
approaches, including review of data sources for re-admission and emergency room visits, to improve the 
detection of SSIs.  All patients who experience infections may not be re-admitted or go to the hospital’s 
emergency department, so there may be some infections that will not be identified by the hospital’s 
reporting system. 
 
For this report, HAIs related to coronary artery bypass graft (CABG) surgery (both with and without the 
harvest of a blood vessel in the lower extremity) and hysterectomy (both vaginal and abdominal) are 
reported in the aggregate.  In the next annual report, the MDPH anticipates having hospital-specific data for 
these measures.   
 
Important data note:  CABG and hip and knee arthroplasty HAIs 
The CABG, hip arthroplasty and knee arthroplasty SSI data represent 7 months of surgical procedures, as 
in these cases, there has been a full year of follow-up for SSIs with implant.   
 
Once the year of observation has occurred for all procedures done between July 2008 and June 2009 and 
appropriate data analysis has been performed, the MDPH will post data on all of the CABG procedures and 
hip and knee arthroplasty HAIs through June 2009.  This is currently anticipated to be available in 
September 2010. 
 
Coronary artery bypass graft (CABG) 
 
CABG surgery, commonly called “bypass surgery”, improves blood flow to the heart.  This procedure is one 
treatment used for people with narrowing and blockage of the heart arteries.  During CABG surgery, a 
healthy vein or artery usually taken from the patient’s own blood vessels in the leg, arm or chest is 
connected or grafted to the blocked coronary artery.  The graft allows blood to go around or “bypass” the 
blocked section of the coronary artery creating a new route to deliver oxygen and nutrients to the heart 
muscle.  The wires used to close the incision stay in the patient’s body permanently and for the purpose of 
NHSN are considered an implant.  Procedures with implants are monitored for infection for one year.   
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24 Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, the Hospital Infection Control Practices Advisory Committee. 
Guideline for the Prevention of Surgical Site Infection, 1999. Infect Control Hosp Epidemiol. 1999; 20:247-278. 
http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/SSI.pdf 
CABG surgery is specialized and only 14 Massachusetts hospitals currently perform these procedures.  The 
patient population represented in this report consists of all patients undergoing CABG surgery requiring an 
implant in Massachusetts adult acute care non-federal hospitals in the period July 1, 2008 through January 
31, 2009.   
 
There are two types of CABG surgery categorized in NHSN.  “CBGB” surgery is one in which there are 
incisions made both in the chest and the “donor site” (the leg, arm, etc).  “CBGC” surgery is one in which 
there is only an incision in the chest.  There are 24 HAIs related to CABG surgery reported in this period. 
 
The expected number of events is calculated using CDC national rates for these infections and applying 
them to the number of procedures performed by the hospitals.  Patients are grouped by the number of risk 
factors they have (0-3).25   
 
Table 13: Surgical Site Infection Rate: CABG Surgery in MA Hospitals, July 1, 2008 – January 31, 200926 
 
Type of 
Surgery 
Number 
of Risk 
Factors27 
Number of 
Hospitals 
Performing 
Number of 
Procedures
Number 
of 
Infections 
(A) 
National 
Rate 
(CDC) 
Number 
of 
Expected 
Infections 
(B) 
SIR 
(A/B) 
Compared to 
National Rate 
CBGB 0-1 14 1,260 21 0.025 31.6 0.66 Not Statistically Different 
CBGB 2-3 14 902 9 0.049 44.0 0.20 Statistically Lower
CBGC 0-3 12 500 3 0.016 7.95 0.38 Not Statistically Different 
CBGB = incisions made both in the chest and the “donor site” 
CBGC = only an incision in the chest 
 
Massachusetts hospitals’ infection rates for CBGB patients with 2-3 risk factors are statistically lower than 
the national rates (the difference is statistically significant, with the upper confidence interval of the SIR not 
including 1.00).     
    
 
Hysterectomy (Vaginal and Abdominal) 
 
Vaginal hysterectomy (VHYS) is a surgical procedure where the uterus is removed through an incision 
made within the vagina leaving no visible scar.  Abdominal hysterectomy (HYST) is the surgical removal of 
the uterus through an incision in the abdominal wall.  Infections related to hysterectomy can be detected for 
up to 30 days.  There are 66 HAIs related to both types of hysterectomy surgery reported in this period. 
 
 
                                                 
25 The risk factors used by the CDC are an ASA (American Society of Anesthesiologists) score higher than 3, a wound class 
classified as contaminated or dirty, and duration of surgery longer than the national mean time for this surgery. 
http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf 
26 These infections represent only those reported in the first seven months of the time period, as a full year of follow-up data is 
available for these procedures.  The Department will post revised numbers showing all HAIs reported through June 30, 2009 in 
September 2010, as soon as the full year of follow-up data is available. 
27 The risk factors used by the CDC are an ASA (American Society of Anesthesiologists) score higher than 3, a wound class 
classified as contaminated or dirty, and duration of surgery longer than the national mean time for this surgery. 
http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf 
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Table 14: Surgical Site Infection Rate: Hysterectomy Surgery in MA Hospitals, July 1, 2008 – June 30, 2009 
 
Type of 
Surgery 
Number 
of Risk 
Factors28 
Number of 
Hospitals 
Performing 
Number of 
Procedures
Number 
of 
Infections 
(A) 
National 
Rate 
(CDC) 
Number 
of 
Expected 
Infections 
(B) 
SIR 
(A/B) 
Compared to 
National Rate 
HYST 0 60 3,204 16 0.011 35.2 0.45 Statistically Lower
HYST 1 57 2,181 20 0.022 48.0 0.42 Statistically Lower
HYST 2-3 38 395 6 0.041 16.0 0.38 Statistically Lower
VHYS 0 55 1,399 10 0.007 10.2 0.98 Not Significantly Different 
VHYS 1-3 56 1,052 14 0.012 12.2 1.15 Not Significantly Different 
HYST = Abdominal Hysterectomy 
VHYS = Vaginal Hysterectomy 
 
Massachusetts hospital deep tissue and organ space SSI rates for abdominal hysterectomy were 
statistically lower than the national rate; rates for vaginal hysterectomy procedures were not significantly 
different.   
 
 
Hip and Knee Arthroplasty 
Hip arthroplasty is surgery to the hip joint where the diseased or damaged hip joint is removed and replaced 
with an artificial implant called a prosthesis.  Knee arthroplasty is a surgical procedure where the diseased 
or damaged part of the knee is removed and replaced with a prosthesis.   
 
There are 78 HAIs related to hip and knee arthroplasty reported during their reporting period (July 2008 
through January 2009). 
 
 
                                                 
28 The risk factors used by the CDC are an ASA (American Society of Anesthesiologists) score higher than 3, a wound class 
classified as contaminated or dirty, and duration of surgery longer than the national mean time for this surgery. 
http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf 
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Table 15:  Surgical Site Infection Rate: Hip and Knee Arthroplasty, July 1, 2008 – January 31, 200929 
 
Type of 
Surgery 
Number 
of Risk 
Factors30 
Number of 
Hospitals 
Performing 
Number of 
Procedures
Number 
of 
Infections 
(A) 
National 
Rate 
(CDC) 
Number 
of 
Expected 
Infections 
(B) 
SIR 
(A/B) 
Compared to 
National Rate 
HPRO 0 62 1,874 5 0.007 12.56 0.40 Statistically Lower
HPRO 1 66 2,959 21 0.014 42.61 0.49 Statistically Lower
HPRO 2-3 57 800 14 0.024 19.20 0.73 Not Statistically Different 
KPRO 0 57 2,970 8 0.006 17.23 0.46 Statistically Lower
KPRO 1 65 3,297 17 0.010 32.64 0.52 Statistically Lower
KPRO 2-3 61 960 13 0.016 15.36 0.85 Not Statistically Different 
HPRO = Hip Arthroplasty 
KPRO = Knee Arthroplasty 
 
These rates and SIRs are calculated on the basis of data available as of the writing of this report.  Revised 
rates and SIRs will be posted when further data are available (see footnote 29).  These updated rates and 
SIRs will almost certainly be somewhat different from those reported here, as more complete information 
will be available at that time. 
 
Massachusetts hospital deep infection SSI rates are statistically below the rates that would be expected for 
both hip and knee arthroplasty, based on national rates for these procedures (the upper confidence interval 
of the SIR not including 1.00.  Only the knee and hip arthroplasty SSI rate for patients with 2-3 risk factors 
were not statistically significantly different from the national rate. 
 
 
Hip Arthroplasty HAIs 
 
 
Table 16:  Hip Arthroplasty Surgical Site Infections Compared to Expected Infections 
 
Hospital Name Total Surgeries
Total 
Infections 
(A) 
Expected 
Infections 
(B) 
SIR 
(A/B) 
Compared to 
National Rate 
Anna Jaques Hospital 45 2 0.57 3.51 Not Statistically Different 
Berkshire Health Systems 86 3 1.09 2.75 Not Statistically Different 
                                                 
29 These infections represent only those reported in the first seven months of the time period, as a full year of follow-up data is not 
available for these procedures.  The Department will post revised numbers showing all HAIs reported through June 30, 2009 in 
September 2010, as soon as the full year of follow-up data is available. 
30 The risk factors used by the CDC are an ASA (American Society of Anesthesiologists) score higher than 3, a wound class 
classified as contaminated or dirty, and duration of surgery longer than the national mean time for this surgery. 
http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf 
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Total Expected Total SIR Compared to Hospital Name Surgeries Infections Infections (A) (B) (A/B) National Rate 
Beth Israel Deaconess Medical 
Center 143 3 1.81 1.66 
Not Statistically 
Different 
Boston Medical Center 93 2 1.18 1.69 Not Statistically Different 
Brigham and Women's Hospital 323 2 4.09 0.49 Not Statistically Different 
Holyoke Medical Center 31 1 0.39 2.55 Not Statistically Different 
Lahey Clinic 203 1 2.57 0.39 Not Statistically Different 
Lowell General Hospital 52 2 0.66 3.04 Not Statistically Different 
Massachusetts General Hospital 274 2 3.47 0.58 Not Statistically Different 
Merrimack Valley Hospital 23 1 0.29 3.43 Not Statistically Different 
Metro West Medical Center- 
Framingham Hospital 21 2 0.27 7.52 
Not Statistically 
Different 
Metro West Medical Center- 
Leonard Morse Hospital 32 1 0.41 2.47 
Not Statistically 
Different 
New England Baptist Hospital 1,092 1 13.83 0.07 Statistically Lower 
Newton-Wellesley Hospital 265 2 3.36 0.59 Not Statistically Different 
North Shore Medical Center - 
Salem Hospital 107 2 1.35 1.48 
Not Statistically 
Different 
Northeast Hospital – Beverly 
Hospital 110 1 1.39 0.72 
Not Statistically 
Different 
Quincy Medical Center 53 1 0.67 1.49 Not Statistically Different 
Saint Vincent Hospital 163 4 2.06 1.94 Not Statistically Different 
Southcoast Health Systems -
Charlton Hospital 99 2 1.25 1.59 
Not Statistically 
Different 
St. Elizabeth's Medical Center 38 1 0.48 2.08 Not Statistically Different 
UMass Memorial Medical Center 312 3 3.95 0.76 Not Statistically Different 
Winchester Hospital 60 1 0.76 1.32 Not Statistically Different 
 
 
Only New England Baptist had hip arthroplasty SSI infection rates that were statistically different from the 
national data, statistically lower.  Hospitals not listed in this chart did not report any infections during this 
reporting period. 
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Some hospitals performed hip arthroplasty surgery and had no SSIs during the reporting period.  The 
number of surgeries performed and the expected number of infections based on national rates is found in 
Table 17.  The number of procedures performed by these hospitals ranged from 1 to 262.   
 
Table 17:  Hospitals with No Hip Arthroplasty Infections. July 2008 – January 2009 
 
Hospital Name Total Surgeries
Total 
Infections 
(A) 
Expected 
Infections 
(B) 
SIR 
(A/B) 
Compared to 
National Rate 
Baystate Medical Center 262 0 3.32 0.00 Not Statistically Different 
South Shore Hospital 143 0 1.81 0.00 Not Statistically Different 
Cape Cod Hospital 125 0 1.58 0.00 Not Statistically Different 
Mount Auburn Hospital 125 0 1.58 0.00 Not Statistically Different 
Southcoast Health Systems -- 
St. Luke's Hospital 90 0 1.14 0.00 
Not Statistically 
Different 
Falmouth Hospital 83 0 1.05 0.00 Not Statistically Different 
Caritas Holy Family Hospital 81 0 1.03 0.00 Not Statistically Different 
North Shore Medical Center - 
Union Hospital 81 0 1.03 0.00 
Not Statistically 
Different 
Jordan Hospital 65 0 0.82 0.00 Not Statistically Different 
Caritas Good Samaritan Medical 
Center 62 0 0.79 0.00 
Not Statistically 
Different 
Tufts Medical Center 62 0 0.79 0.00 Not Statistically Different 
Cooley Dickinson Hospital 57 0 0.72 0.00 Not Statistically Different 
Caritas Norwood Hospital 53 0 0.67 0.00 Not Statistically Different 
Emerson Hospital 53 0 0.67 0.00 Not Statistically Different 
Hallmark Health Corp- Melrose-
Wakefield 53 0 0.67 0.00 
Not Statistically 
Different 
Milford Regional Hospital 43 0 0.54 0.00 Not Statistically Different 
Brockton Hospital (Signature) 41 0 0.52 0.00 Not Statistically Different 
Sturdy Memorial Medical Center 40 0 0.51 0.00 Not Statistically Different 
Faulkner 36 0 0.46 0.00 Not Statistically Different 
Saints Memorial Medical Center 35 0 0.44 0.00 Not Statistically Different 
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Hospital Name Total Surgeries
Total Expected SIR Compared to Infections Infections 
(A) (B) (A/B) National Rate 
Morton Hospital and Medical 
Center 32 0 0.41 0.00 
Not Statistically 
Different 
Nthern Berkshire Health Sys 
(North Adams Reg Hos) 32 0 0.41 0.00 
Not Statistically 
Different 
St. Anne's Hospital 31 0 0.39 0.00 Not Statistically Different 
Mercy Medical Center 30 0 0.38 0.00 Not Statistically Different 
Beth Israel Deaconess Medical 
Center Needham 28 0 0.35 0.00 
Not Statistically 
Different 
Marlborough Hospital 28 0 0.35 0.00 Not Statistically Different 
Lawrence General Hospital 24 0 0.30 0.00 Not Statistically Different 
Cambridge Health Alliance - 
Cambridge Hospital 23 0 0.29 0.00 
Not Statistically 
Different 
Caritas Carney Hospital 23 0 0.29 0.00 Not Statistically Different 
Franklin Medical Center 23 0 0.29 0.00 Not Statistically Different 
Health Alliance Hospital 21 0 0.27 0.00 Not Statistically Different 
Lawrence Memorial Hospital 20 0 0.25 0.00 Not Statistically Different 
Milton Hospital 20 0 0.25 0.00 Not Statistically Different 
Southcoast Health Systems -- 
Tobey Hospital 16 0 0.20 0.00 
Not Statistically 
Different 
Cambridge Health Alliance - 
Whidden Memorial Hospital 11 0 0.14 0.00 
Not Statistically 
Different 
Heywood Hospital 9 0 0.11 0.00 Not Statistically Different 
Noble Hospital 9 0 0.11 0.00 Not Statistically Different 
Wing Memorial Hospital 8 0 0.10 0.00 Not Statistically Different 
Harrington Memorial Hospital 7 0 0.09 0.00 Not Statistically Different 
Martha's Vineyard Hospital 7 0 0.09 0.00 Not Statistically Different 
Nashoba Valley Medical Center 6 0 0.08 0.00 Not Statistically Different 
Fairview 5 0 0.06 0.00 Not Statistically Different 
Cambridge Health Alliance -
Somerville Hospital 2 0 0.03 0.00 
Not Statistically 
Different 
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Hospital Name Total Surgeries
Total Expected SIR Compared to Infections Infections 
(A) (B) (A/B) National Rate 
Northeast Hospital - Addison 
Gilbert 2 0 0.03 0.00 
Not Statistically 
Different 
Athol Hospital 1 0 0.01 0.00 Not Statistically Different 
 
 
 
Knee Arthroplasty HAIs 
 
 
Table 18:  Knee Arthroplasty Surgical Site Infections Compared to Expected Infections 
 
New England Baptist Hospital’s rate was significantly different from the expected, statistically lower (the 
upper confidence interval of the SIR not including 1.00).  St. Vincent Hospital’s rate was significantly 
different from the expected, statistically higher. 
 
Hospital Name Total Surgeries
Total 
Infections 
(A) 
Expected 
Infections 
(B) 
SIR 
(A/B) 
Compared to 
National Rate 
Anna Jaques Hospital 36 1 0.32 3.11 Not Statistically Different 
Beth Israel Deaconess Medical 
Center 159 2 1.42 1.41 
Not Statistically 
Different 
Brigham and Women's Hospital 451 2 4.03 0.50 Not Statistically Different 
Brockton Hospital (Signature) 55 1 0.49 2.04 Not Statistically Different 
Cambridge Health Alliance - 
Cambridge Hospital 28 1 0.25 4.00 
Not Statistically 
Different 
Caritas Holy Family Hospital 108 1 0.96 1.04 Not Statistically Different 
Falmouth Hospital 153 1 1.37 0.73 Not Statistically Different 
Lahey Clinic 288 2 2.57 0.78 Not Statistically Different 
Lowell General Hospital 76 3 0.68 4.42 Not Statistically Different 
Massachusetts General Hospital 274 2 2.45 0.82 Not Statistically Different 
Metro West Medical Center- 
Leonard Morse Hospital 59 1 0.53 1.90 
Not Statistically 
Different 
Mount Auburn Hospital 173 1 1.54 0.65 Not Statistically Different 
New England Baptist Hospital 1,320 4 11.78 0.34 Significantly Lower 
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Total Expected Total SIR Compared to Hospital Name Surgeries Infections Infections (A) (B) (A/B) National Rate 
Newton-Wellesley Hospital 193 1 1.72 0.58 Not Statistically Different 
Noble Hospital 26 1 0.23 4.31 Not Statistically Different 
North Shore Medical Center - 
Salem Hospital 159 1 1.42 0.70 
Not Statistically 
Different 
Quincy Medical Center 50 1 0.45 2.24 Not Statistically Different 
Saint Vincent Hospital 206 6 1.84 3.26 Significantly Higher 
South Shore Hospital 153 1 1.37 0.73 Not Statistically Different 
Southcoast Health Systems -- 
Charlton Hospital 160 1 1.43 0.70 
Not Statistically 
Different 
Southcoast Health Systems -- 
St. Luke's Hospital 136 2 1.21 1.65 
Not Statistically 
Different 
Tufts Medical Center 51 1 0.46 2.20 Not Statistically Different 
Winchester Hospital 131 1 1.17 0.86 Not Statistically Different 
 
Some hospitals performed knee arthroplasty surgeries and had no SSIs during this time period.  The 
number of surgeries performed and the expected number of infections based on national rates is found in 
Table 19. 
 
 
Table 19:  Hospitals with No Knee Arthroplasty Infections July 2008 – January 2009 
 
Hospital Name Total Surgeries
Total 
Infections 
(A) 
Expected 
Infections 
(B) 
SIR 
(A/B) 
Compared to 
National Rate 
Baystate Medical Center 377 0 3.37 0.00 Not Statistically Different 
UMass Memorial Medical Center 290 0 2.59 0.00 Not Statistically Different 
Northeast Hospital - Beverly 
Hospital 176 0 1.57 0.00 
Not Statistically 
Different 
Boston Medical Center 138 0 1.23 0.00 Not Statistically Different 
Cape Cod Hospital 135 0 1.21 0.00 Not Statistically Different 
Faulkner 128 0 1.14 0.00 Not Statistically Different 
Jordan Hospital 128 0 1.14 0.00 Not Statistically Different 
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Hospital Name Total Surgeries
Total Expected SIR Compared to Infections Infections 
(A) (B) (A/B) National Rate 
Berkshire Health Systems 112 0 1.00 0.00 Not Statistically Different 
Caritas Good Samaritan Medical 
Center 99 0 0.88 0.00 
Not Statistically 
Different 
North Shore Medical Center - 
Union Hospital 89 0 0.79 0.00 
Not Statistically 
Different 
Morton Hospital and Medical 
Center 86 0 0.77 0.00 
Not Statistically 
Different 
Mercy Medical Center 72 0 0.64 0.00 Not Statistically Different 
Cooley Dickinson Hospital 58 0 0.52 0.00 Not Statistically Different 
Marlborough Hospital 58 0 0.52 0.00 Not Statistically Different 
Milford Regional Hospital 57 0 0.51 0.00 Not Statistically Different 
St. Elizabeth's Medical Center 57 0 0.51 0.00 Not Statistically Different 
Saints Memorial Medical Center 55 0 0.49 0.00 Not Statistically Different 
Hallmark Health Corp- Melrose-
Wakefield 53 0 0.47 0.00 
Not Statistically 
Different 
Caritas Norwood Hospital 52 0 0.46 0.00 Not Statistically Different 
Health Alliance Hospital 51 0 0.46 0.00 Not Statistically Different 
Sturdy Memorial Medical Center 51 0 0.46 0.00 Not Statistically Different 
Emerson Hospital 48 0 0.43 0.00 Not Statistically Different 
Heywood Hospital 48 0 0.43 0.00 Not Statistically Different 
Holyoke Medical Center 46 0 0.41 0.00 Not Statistically Different 
Milton Hospital 44 0 0.39 0.00 Not Statistically Different 
Nthern Berkshire Health Sys 
(North Adams Reg Hos) 36 0 0.32 0.00 
Not Statistically 
Different 
Merrimack Valley Hospital 32 0 0.29 0.00 Not Statistically Different 
Southcoast Health Systems -- 
Tobey Hospital 29 0 0.26 0.00 
Not Statistically 
Different 
Caritas Carney Hospital 25 0 0.22 0.00 Not Statistically Different 
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Hospital Name Total Surgeries
Total Expected SIR Compared to Infections Infections 
(A) (B) (A/B) National Rate 
St. Anne's Hospital 23 0 0.21 0.00 Not Statistically Different 
Harrington Memorial Hospital 18 0 0.16 0.00 Not Statistically Different 
Metro West Medical Center- 
Framingham Hospital 18 0 0.16 0.00 
Not Statistically 
Different 
Lawrence Memorial Hospital 14 0 0.13 0.00 Not Statistically Different 
Fairview 13 0 0.12 0.00 Not Statistically Different 
Beth Israel Deaconess Medical 
Center Needham 12 0 0.11 0.00 
Not Statistically 
Different 
Franklin Medical Center 12 0 0.11 0.00 Not Statistically Different 
Nashoba Valley Medical Center 11 0 0.10 0.00 Not Statistically Different 
Baystate Mary Lane 7 0 0.06 0.00 Not Statistically Different 
Lawrence General Hospital 6 0 0.05 0.00 Not Statistically Different 
Wing Memorial Hospital 6 0 0.05 0.00 Not Statistically Different 
Cambridge Health Alliance -
Somerville Hospital 4 0 0.04 0.00 
Not Statistically 
Different 
Cambridge Health Alliance - 
Whidden Memorial Hospital 3 0 0.03 0.00 
Not Statistically 
Different 
Martha's Vineyard Hospital 3 0 0.03 0.00 Not Statistically Different 
Northeast Hospital - Addison 
Gilbert 2 0 0.02 0.00 
Not Statistically 
Different 
 
 
 
Time to Detection 
 
The time it takes to detect an SSI varies greatly, depending on the type of event.  For knee arthroplasty, the 
average time to detection was nearly 104 days (approximately 3 ½ months).  To identify infections after 
discharge and prevent underestimations of SSIs, hospital infection control programs routinely conduct a 
process known as post discharge surveillance.  Although there is no standard way to this information, 
hospitals use various approaches, including review of data sources for re-admission and emergency room 
visits, to improve the detection of SSIs.  All patients who experience infections may not be re-admitted or go 
to the hospital’s emergency department, so there may be some infections that will not be identified by the 
hospital’s reporting system. 
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Table 20: Detection of Surgical Site Infections 
 
Range of Days to 
Detection Procedure Events 
Average 
Detection 
(days) 
Minimum Maximum
When Detected 
During Admission 5 
Post-Discharge Surveillance 1 CBGB 30 34.63 5 183 
Readmission 24
During Admission 2 
Post-Discharge Surveillance 0 CBGC 3 29 10 50 
Readmission 1 
During Admission 3 
Post-Discharge Surveillance 3 VHYS 24 11.21 1 22 
Readmission 18
During Admission 2 
Post-Discharge Surveillance 7 HYST 42 11.24 1 28 
Readmission 33
During Admission 0 
Post-Discharge Surveillance 3 KPRO 38 122.6 1 353 
Readmission 35
During Admission 13
Post-Discharge Surveillance 1 HPRO 40 57.6 1 324 
Readmission 36
 
 
 
Additional Data 
 
Race/Ethnicity Data 
 
Understanding and preventing racial and ethnic disparities in healthcare is a high MDPH priority.  The 
established federal NHSN system has limited ability to collect race and ethnicity data, as those data 
elements are not required for participation.  In order to meet the Massachusetts requirement for submission 
of data on race and expanded ethnicity, beginning January 1, 2009, all acute care hospitals were mandated 
to submit this information using custom NHSN fields.  Each hospital was required to manually set up and 
enter all data in the specified custom fields using the MA Division of Health Care Finance and Policy codes.  
While the initial focus of the quality assurance reports has been to ensure the accuracy of HAI measures at 
the facility level, the addition of a data manager to the program will assist efforts to evaluate submission of 
race and ethnicity data.   
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Current Status of HAI Activities in Massachusetts 
 
Sharing of Best Practices 
The HAI Expert Panel recommended a comprehensive set of evidence based prevention guidelines or “best 
practices” for implementation in Massachusetts hospitals31.  “Best practices” are strategies, activities or 
approaches that have been shown through research and evaluation to be effective in reducing the risk of 
HAI.    
 
Infection Prevention Unit Activities   
To actively support the use of the evidence-based best practices, MDPH implemented an Infection 
Prevention Unit within the Division of Health Care Quality.  For its first project, MDPH infection 
preventionists (IP) with extensive HAI experience developed a detailed on-site survey tool for individual 
hospital infection prevention programs to use to look at their current programs.  The IPs conducted site 
visits in each acute care hospital to encourage an open discussion on current practices and innovative 
programs at the hospital.  In addition, they provided guidance on implementation of best practices, 
collection and submission of HAI data, and they addressed programmatic concerns.   
 
In April 2010, the IPs will begin unannounced infection prevention and control focused surveys of all acute 
care hospitals.  They will conduct reviews to verify compliance with regulations, associated guidelines and 
relevant best practices.  If hospitals do not meet established standards for infection prevention they will be 
required to submit a written plan to MDPH to identify the corrective actions to be taken to address deficient 
practices.   
 
Education and Training 
Support for Hospitals  
Before NHSN reporting began, hospitals completed user specific CDC/NHSN training.  Additional technical 
assistance and training on NHSN enrollment procedures, standard definitions and reporting measures has 
been provided for all hospitals. Ongoing support for hospitals is provided by MDPH staff in consultation with 
CDC.   
 
Massachusetts Coalition for the Prevention of Medical Errors 
MDPH supports the Massachusetts Coalition for the Prevention of Medical Errors (the Coalition) 
collaborative programming designed to help hospitals in their work to prevent healthcare associated 
infections (HAIs).  Working with the Massachusetts Hospital Association (MHA), MDPH, and the Betsy 
Lehman Center for Patient Safety, the Coalition’s goal has been to enlist 100% of acute care hospitals, and 
accelerate progress in infection prevention in those hospitals by sharing local and national best practices, 
tools and resources, and implementation strategies, as well as maintaining top leadership support.   
 
The Coalition has held a number of seminars for professionals on infection prevention and approaches for 
promoting quality improvement. All hospitals participated in one or more of these trainings.  Programs were 
also developed to ensure senior hospital leadership involvement in this initiative.  As a result of these 
focused meetings senior leaders from all hospitals signed a letter of commitment prioritizing infection 
prevention for their facility.  To promote the sharing of effective strategies the Coalition has published and 
distributed a collection of 34 successful prevention projects reported by 24 hospitals.32   
 
 
                                                 
31 http://www.mass.gov/Eeohhs2/docs/dph/patient_safety/haipcp_final_report_pt1.pdf    
   http://www.mass.gov/Eeohhs2/docs/dph/patient_safety/haipcp_final_report_pt2.pdf 
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32 http://www.macoalition.org/Initiatives/docs/09-27_MACoalition_booklet_web.pdf 
The Massachusetts Neonatal Quality Improvement Collaborative  
Mass NeoQIC is a statewide quality improvement organization representing neonatologists from all 10 level 
3 neonatal intensive care units (NICUs) in Massachusetts.  NICUs provide care for newborn infants with 
extreme prematurity or who are critically ill or require surgical intervention.  MassNeoQIC has approached 
MDPH to work with them in their efforts to reduce preventable infections.  MDPH staff will collaborate with 
MassNeoQIC in identification of best practices, reporting of NICU measures of infection and utilization of the 
data to improve the care of our smallest and most vulnerable patients.  
 
Consumer Targeted Information  
The Partnership for Healthcare Excellence is a broad-based coalition with participants from every segment 
of the health care community whose aim is to educate and motivate consumers to improve the safety and 
effectiveness of their own healthcare.  Membership includes consumer associations, disease and advocacy 
organizations, doctors and insurers, business groups, labor, public health advocates and other health care 
leaders.     
 
In efforts to raise awareness and address the steps consumers can take to reduce infection, MDPH 
supported public information campaigns conducted by the Partnership for Healthcare Excellence.  The 
Partnership produced a fact sheet accessible online that provides concrete actions to help prevent infection.  
The fact sheet is also available in Spanish, Portuguese, Vietnamese and Cambodian.33 
 
National Efforts to Address HAI 
HAI as an emerging public health issue has received increasing attention from the public, healthcare 
providers, the media and legislators.  Although there are many state, federal and private agencies working 
to prevent the occurrence of HAI, until recently a coordinated national effort had not been developed.   
 
In January 2009, the U.S. Department of Health and Human Services (HHS) published an Action Plan to 
Prevent Healthcare-Associated Infections.34  The overall goal of the plan is to improve the coordination of 
federal activities and resources to accelerate and maximize their impact on reducing HAI.  The plan 
establishes five year national goals and outlines an integrated approach to improve the management of HAI 
initiatives.  It identifies prioritized areas for prevention and includes recommendations for research, and the 
enhanced use and quality of the metrics and supporting systems needed to assess progress towards 
meeting the targets.  Meeting the challenge of HAI prevention will also require effective collaboration with 
national, state public and private sector partners.   
 
American Recovery and Reinvestment Act of 2009  
The American Recovery and Reinvestment Act (ARRA) of 2009, Public Law 111-5 was signed into law on 
February 17, 2009.  The primary purpose of this funding is to promote economic stimulus, maximize job 
creation, and job retention.  In February 2009, the US Department of Health and Human Services (HHS) 
appropriated $40 million to state health departments for efforts to prevent HAI.   
 
In August, 2009, the Center for Disease Control and Prevention announced the award of a $1.5 million 
grant to Massachusetts to carry out activities to meet the expectations described in the U.S. Department of 
Health and Human Services 2009 Action Plan to Prevent Healthcare-Associated Infections.  This one time 
only funding to be distributed over a two year period will complement existing state efforts to address HAIs 
and support the following activities: 
                                                 
33 http://www.partnershipforhealthcare.org/patients_and_caregivers/preventing_infection/ 
34 http://www.hhs.gov/ophs/initiatives/hai/infection.html 
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 Coordination and Reporting of State HAI Prevention Efforts 
MDPH will enhance efforts to coordinate and implement HAI prevention activities and report on 
progress toward reductions in selected HHS Action Plan Targets.  Designation of a dedicated 
Coordinator who will focus on HAI prevention and development and implementation of the State 
HAI Plan are new activities under the ARRA funding.   
 Detection and Reporting of HAI Surveillance Data 
Support for this initiative includes plans to improve the quality of the recently implemented 
NHSN-based reporting system with data cleaning and validation activities.  MDPH is working 
with JSI Research and Training Institute, Inc., to develop and implement a sustainable system of 
data validation.  In addition, there will be time-phased expansion of metrics tracked in order to 
ultimately assess progress on 5 of 7 HHS Action Plan Targets.  This expansion will be facilitated 
by enhanced capacity for electronic laboratory reporting (ELR). 
 Establishing a Prevention Collaborative 
MDPH has partnered with the Massachusetts Coalition for the Prevention of Medical Errors to 
conduct two collaborative initiatives targeting reductions in central line associated blood stream 
infection (CLABSI), and multi-drug resistant organisms (MDROs).  The comprehensive infection 
prevention training is intended to promote measureable progress toward the national prevention 
targets outlined in the HHS Action Plan to Prevent HAIs. 
 
Massachusetts State HAI Action Plan  
The 2009 ARRA bill required states receiving funds to certify that they would submit a plan to reduce HAIs 
to the Secretary of Health and Human Services (HHS) no later than January 1, 2010.  As directed, MDPH 
presented the Massachusetts State HAI Prevention Plan to HHS on December 30, 2009.  The adoption of a 
formal plan identifies state level long range prevention targets and is consistent with national five year HHS 
goals and objectives.  The plan was created with input from the TAG.  Implementation of the 
recommendations detailed in the Plan will be reviewed on an ongoing basis.  Additional goals, objectives 
and activities will be developed as areas of need are identified.  The plan is available for review on the 
following website.  www.mass.gov/dph/dhcq 
 
To see what other states are planning please access the following clickable map. 
http://www.cdc.gov/HAI/recoveryact/map.html 
 
 
 
